| |
Latest 10 SEC filings (by transaction date) for DCPH within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 20/24 | Feb 16/24 | Kelly Thomas Patrick | Direct Ownership | Common Stock | S - Open market or private sale | -3,010 | $15.62 |
Feb 20/24 | Feb 16/24 | Martin Daniel C. | Direct Ownership | Common Stock | S - Open market or private sale | -2,267 | $15.62 |
Feb 20/24 | Feb 16/24 | Sherman Matthew L | Direct Ownership | Common Stock | S - Open market or private sale | -2,615 | $15.62 |
Feb 20/24 | Feb 16/24 | Pitman Jama | Direct Ownership | Common Stock | S - Open market or private sale | -2,267 | $15.62 |
Feb 20/24 | Feb 15/24 | Kelly Thomas Patrick | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 69,100 | |
Feb 20/24 | Feb 15/24 | Kelly Thomas Patrick | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 17,275 | |
Feb 20/24 | Feb 15/24 | Hoerter Steven L. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 298,100 | |
Feb 20/24 | Feb 15/24 | Dhanak Dashyant | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 69,100 | |
Feb 20/24 | Feb 15/24 | Dhanak Dashyant | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 17,275 | |
Feb 20/24 | Feb 15/24 | Martin Daniel C. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 38,900 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for DCPH within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 20/24 | Feb 15/24 | Kelly Thomas Patrick | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 69,100 | |
Feb 20/24 | Feb 16/24 | Kelly Thomas Patrick | Direct Ownership | Common Stock | S - Open market or private sale | -3,010 | $15.62 |
Feb 20/24 | Feb 15/24 | Kelly Thomas Patrick | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 17,275 | |
Feb 20/24 | Feb 15/24 | Hoerter Steven L. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 298,100 | |
Feb 20/24 | Feb 15/24 | Dhanak Dashyant | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 69,100 | |
Feb 20/24 | Feb 15/24 | Dhanak Dashyant | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 17,275 | |
Feb 20/24 | Feb 15/24 | Martin Daniel C. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 38,900 | |
Feb 20/24 | Feb 16/24 | Martin Daniel C. | Direct Ownership | Common Stock | S - Open market or private sale | -2,267 | $15.62 |
Feb 20/24 | Feb 15/24 | Martin Daniel C. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 9,725 | |
Feb 20/24 | Feb 15/24 | Sherman Matthew L | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 69,100 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |